Currently, treatment for severe hypoglycemia is limited to intramuscular injection of a glucagon formulation, which is commercially available as an emergency kit consisting of lyophilized glucagon powder that must be mixed with diluents immediately prior to injection. This evidence concerns the gene GCG and Hypoglycemia.